Abstract
(Int J Obstet Anesth. 2020;44:116–121) Ketorolac is commonly used to manage postcesarean delivery pain. While the manufacturer recommends an intravenous (IV) dose of 30 mg for adults under age 65, a dose of 15 mg is sometimes used. There is a lack of data on the efficacy, outcomes, or side effects associated with a higher or lower dose. This study was conducted in a center that uses both doses for postcesarean analgesia and aimed to compare analgesic efficacy for each dose. The hypothesis was that the 30 mg dose would be associated with lower opioid use.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
